Hydrogel rectum-prostate spacers and anterior-oblique proton beams ”
暂无分享,去创建一个
A. Zietman | J. Efstathiou | H. Paganetti | Hsiao-Ming Lu | O. Cahlon | Shikui Tang | J. Voog | T. Underwood | M. Moteabbed | E. Soffen
[1] D. Low,et al. Plan quality and dosimetric association of patient-reported rectal and urinary toxicities for prostate stereotactic body radiotherapy. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] Annie Gao,et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial , 2016, The Lancet. Oncology.
[3] Y. Lotan,et al. Decision analysis model evaluating the cost of a temporary hydrogel rectal spacer before prostate radiation therapy to reduce the incidence of rectal complications. , 2016, Urologic oncology.
[4] K. Herfarth,et al. Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI Trial. , 2016, International journal of radiation oncology, biology, physics.
[5] Harald Paganetti,et al. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy. , 2016, International journal of radiation oncology, biology, physics.
[6] H. Katoh,et al. Changes in Rectal Dose Due to Alterations in Beam Angles for Setup Uncertainty and Range Uncertainty in Carbon-Ion Radiotherapy for Prostate Cancer , 2016, PloS one.
[7] K. Parodi,et al. Clinical commissioning of an in vivo range verification system for prostate cancer treatment with anterior and anterior oblique proton beams , 2015, Physics in medicine and biology.
[8] V. Heikkilä. PEG spacer gel and adaptive planning vs single plan in external prostate radiotherapy--clinical dosimetry evaluation. , 2015, The British journal of radiology.
[9] J. Deasy,et al. Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancer , 2015, Acta oncologica.
[10] L. Muren,et al. A method for evaluation of proton plan robustness towards inter-fractional motion applied to pelvic lymph node irradiation , 2015, Acta oncologica.
[11] H. Woo,et al. Rectal ulcer associated with SpaceOAR hydrogel insertion during prostate brachytherapy , 2014, BMJ Case Reports.
[12] C. Deville,et al. Effect of intrafraction prostate motion on proton pencil beam scanning delivery: a quantitative assessment. , 2013, International journal of radiation oncology, biology, physics.
[13] M. Santoro,et al. Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years , 2013, Radiation oncology.
[14] H Paganetti,et al. TOPAS: an innovative proton Monte Carlo platform for research and clinical applications. , 2012, Medical physics.
[15] I. Toma-Dasu,et al. Prostate alpha/beta revisited – an analysis of clinical results from 14 168 patients , 2012, Acta oncologica.
[16] C. King,et al. Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes , 2011, Radiation oncology.
[17] C. Lawton. Radiation dose–volume effects of the urinary bladder , 2011 .
[18] J. Deasy,et al. Radiation dose-volume effects in radiation-induced rectal injury. , 2010, International journal of radiation oncology, biology, physics.
[19] Alexei Trofimov,et al. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison. , 2007, International journal of radiation oncology, biology, physics.
[20] Rick Chappell,et al. Is α/β for prostate tumors really low? , 2001 .
[21] D J Brenner,et al. Fractionation and protraction for radiotherapy of prostate carcinoma. , 1999, International journal of radiation oncology, biology, physics.